Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Neurological Medicine
Volume 2017, Article ID 3247034, 6 pages
https://doi.org/10.1155/2017/3247034
Case Report

Open-Label Fosmetpantotenate, a Phosphopantothenate Replacement Therapy in a Single Patient with Atypical PKAN

1Neurology Clinics, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus
2Clinical Genetics Clinic, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus
3European University Cyprus, Nicosia, Cyprus
4Retrophin Inc., New York, NY, USA

Correspondence should be addressed to Kleopas A. Kleopa; yc.ca.gnic@apoelk

Received 24 November 2016; Revised 2 March 2017; Accepted 12 March 2017; Published 16 April 2017

Academic Editor: Isabella Laura Simone

Copyright © 2017 Yiolanda-Panayiota Christou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Yiolanda-Panayiota Christou, George A. Tanteles, Elena Kkolou, et al., “Open-Label Fosmetpantotenate, a Phosphopantothenate Replacement Therapy in a Single Patient with Atypical PKAN,” Case Reports in Neurological Medicine, vol. 2017, Article ID 3247034, 6 pages, 2017. https://doi.org/10.1155/2017/3247034.